PDGF-CC induces tissue factor expression: Role of PDGF receptor α/β

Basic Research in Cardiology

Volumn 105, Issue 3, 2010, Pages 349-356

  Gebhard, Catherine ^a,b   Akhmedov, Alexander ^a   Mocharla, Pavani ^a   Angstenberger, Jonas ^a   Sahbai, Saba ^a   Camici, Giovanni G ^a   Lüscher, Thomas F ^a,b   Tanner, Felix C ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Arterial thrombosis; Microvascular endothelial cells; Monocytes; PDGF; Tissue factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BLOCKING ANTIBODY; GROWTH FACTOR; HETERODIMER; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR CC; STRESS ACTIVATED PROTEIN KINASE; THROMBOPLASTIN; UNCLASSIFIED DRUG; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; FLAVONOID; LYMPHOKINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR C; PLATELET-DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR C;

AORTA; ARTICLE; CELL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MICROVASCULATURE; MONOCYTE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; WHOLE CELL; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY;

CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOKINES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RNA, MESSENGER; THROMBOPLASTIN;

EID: 77952749685     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-009-0060-0     Document Type: Article

References (33)

1. Badimon JJ, Badimon L, Turitto VT, Fuster V (1991) Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model. Arterioscler Thromb 11:395
2. Bar RS, Boes M, Booth BA, Dake BL, Henley S, Hart MN (1989) The effects of platelet-derived growth factor in cultured microvessel endothelial cells. Endocrinology 124:1841
3. Bowen-Pope DF, Hart CE, Seifert RA (1989) Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptor. J Biol Chem 264:2502
4. Carr ME (2001) Diabetes mellitus: a hypercoagulable state. J Diabetes Complicat 15:44
5. Cospedal R, Abedi H, Zachary I (1999) Platelet-derived growth factor-BB (PDGF-BB) regulation of migration and focal adhesion kinase phosphorylation in rabbit aortic vascular smooth muscle cells: roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinases. Cardiovasc Res 41:708
6. Ernofsson M, Siegbahn A (1996) Platelet-derived growth factorBB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. Thromb Res 83:307
7. Fang L, Yan Y, Komuves LG, Yonkovich S, Sullivan CM, Stringer B, Galbraith S, Lokker NA, Hwang SS, Nurden P, Phillips DR, Giese NA (2004) PDGF C is a selective alpha platelet-derived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle. Arterioscler Thromb Vase Biol 24:787
8. Faraone D, Aguzzi MS, Ragone G, Russo K, Capogrossi MC, Facchiano A (2006) Heterodimerization of FGF-receptor 1 and PDGF-receptor-alpha: a novel mechanism underlying the inhibitory effect of PDGF-BB on FGF-2 in human cells. Blood 107:1896
9. Ferns GA, Avades TY (2000) The mechanisms of coronary restenosis: insights from experimental models. Int J Exp Pathol 81:63
10. Fredriksson L, Li H, Fieber C, Li X, Eriksson U (2004) Tissue plasminogen activator is a potent activator of PDGF-CC. EMBO J 23:3793
11. Gebhard C, Stampfli SF, Gebhard CE, Akhmedov A, Breitenstein A, Camici GG, Holy EW, Luscher TF, Tanner FC (2009) Guggulsterone, an anti-inflammatory phytosterol, inhibits tissue factor and arterial thrombosis. Basic Res Cardiol 104:285
12. Giese NA, Marijianowski MM, McCook O, Hancock A, Ramakrishnan V, Fretto LJ, Chen C, Kelly AB, Koziol JA, Wilcox JN, Hanson SR (1999) The role of alpha and beta platelet-derived growth factor receptor in the vascular response to injury in nonhuman primates. Arterioscler Thromb Vase Biol 19:900
13. Gilbertson DG, Duff ME, West JW, Kelly JD, Sheppard PO, Hofstrand PD, Gao Z, Shoemaker K, Bukowski TR, Moore M, Feldhaus AL, Humes JM, Palmer TE, Hart CE (2001) Plateletderived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem 276:27406
14. Heldin CH, Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283
15. Holvoet P, Collen D (1997) Thrombosis and atherosclerosis. Curr Opin Lipidol 8:320
16. Inaba T, Shimano H, Gotoda T, Harada K, Shimada M, Ohsuga J, Watanabe Y, Kawamura M, Yazaki Y, Yamada N (1993) Expression of platelet-derived growth factor beta receptor on human monocyte-derived macrophages and effects of plateletderived growth factor BB dimer on the cellular function. J Biol Chem 268:24353
17. Kalsch T, Elmas E, Nguyen XD, Suvajac N, Kluter H, Borggrefe M, Dempfle CE (2007) Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation. Basic Res Cardiol 102:460
18. 18. Kamimura M, Bea F, Akizawa T, Katus HA, Kreuzer J, Viedt C (2004) Platelet-derived growth factor induces tissue factor expression in vascular smooth muscle cells via activation of Egr1. Hypertension 44:944 (Pubitemid 39577426)
19. Kozaki K, Kaminski WE, Tang J, Hollenbach S, Lindahl P, Sullivan C, Yu JC, Abe K, Martin PJ, Ross R, Betsholtz C, Giese NA, Raines EW (2002) Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice. Am J Pathol 161:1395
20. Li X, Ponten A, Aase K, Karlsson L, Abramsson A, Uutela M, Backstrom G, Hellstrom M, Bostrom H, Li H, Soriano P, Betsholtz C, Heldin CH, Alitalo K, Ostman A, Eriksson U (2000) PDGF-C is a new protease-activated ligand for the PDGF alphareceptor. Nat Cell Biol 2:302
21. Lin ZH, Fukuda N, Suzuki R, Takagi H, Ikeda Y, Saito S, Matsumoto K, Kanmatsuse K, Mugishima H (2004) Adenovirusencoded hammerhead ribozyme to PDGF A-chain mRNA inhibits neointima formation after arterial injury. J Vase Res 41:305
22. Marx M, Perlmutter RA, Madri JA (1994) Modulation of plateletderived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 93:131 (Pubitemid 24030829)
23. Murray JJ, Nowak J, Oates JA, FitzGerald GA (1990) Plateletvessel wall interactions in individuals who smoke cigarettes. Adv Exp Med Biol 273:189
24. Reigstad LJ, Sande HM, Fluge O, Bruland O, Muga A, Varhaug JE, Martinez A, Lillehaug JR (2003) Platelet-derived growth factor (PDGF)-C, a PDGF family member with a vascular endothelial growth factor-like structure. J Biol Chem 278:17114 (Pubitemid 36799589)
25. Schecter AD, Giesen PL, Taby O, Rosenfield CL, Rossikhina M, Fyfe BS, Kohtz DS, Fallon JT, Nemerson Y, Taubman MB (1997) Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest 100:2276 (Pubitemid 27500150)
26. Sommeijer DW, Hansen HR, van OR, Hamulyak K, van Zanten AP, Meesters E, Spronk HM, ten CH (2006) Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with Type 2 diabetes. J Thromb Haemost 4:574
27. Stahli BE, Camici GG, Steffel J, Akhmedov A, Shojaati K, Graber M, Luscher TF, Tanner FC (2006) Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation. Circ Res 99:149 (Pubitemid 44297038)
28. Steffel J, Akhmedov A, Greutert H, Luscher TF, Tanner FC (2005) Histamine induces tissue factor expression: implications for acute coronary syndromes. Circulation 112:341
29. Steffel J, Luscher TF, Tanner FC (2006) Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113:722 (Pubitemid 43754336)
30. Uutela M, Lauren J, Bergsten E, Li X, Horelli-Kuitunen N, Eriksson U, Alitalo K (2001) Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFC genes. Circulation 103:2242 (Pubitemid 32433712)
31. Xuereb JM, Sie P, Boneu B, Constans J (2000) Inhibition of tissue factor synthesis by disruption of ERK kinases and PKC signaling pathways in human vascular SMCs. Thromb Haemost 84:129
32. Xuereb JM, Sie P, Boneu B, Constans J (1997) Up-regulation of tissue factor expression by platelet-derived growth factor in human vascular smooth muscle cells in culture-role of mitogenactivated protein kinase and effects of intracellular cyclic AMP. Thromb Haemost 78:1520
33. Zumbach M, Hofmann M, Borcea V, Luther T, Kotzsch M, Müller M, Hergesell O, Andrassy K, Ritz E, Ziegler R, Wahl P, Nawroth PP (1997) Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes 105:206